ATAI (AtaiBeckley) FFO


ATAI AtaiBeckley Inc ATAI
51 GF Score
Price $4.58
GF Value $7.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is AtaiBeckley FFO?

FFO (Funds from operations) only applies to REITs.

ATAI
51GF Score
AtaiBeckley Inc ATAI
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (ATAI) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of $4.58 is trading 38.5% below its estimated GF Value™ of $7.45. GuruFocus considers AtaiBeckley to be Possible Value Trap.

Key valuation signals for ATAI:

  • FFO:
  • GF Value™: $7.45 vs. price of $4.58 (38.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the ATAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges B72:Germany
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
51GF Score

Get the complete analysis for ATAI

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.58
Price
$7.45
GF Value